OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
741957

Mortech Corp

Commodity ChemicalsVerified

Mortech Corp's capital structure is characterized by a low debt-to-equity ratio of 0.08, indicating a conservative leverage profile, and a high current ratio of 9.59, suggesting strong short-term liquidity. The company holds significant cash and equivalents of TWD 142,675,000, which is 44.4% of total assets, providing a buffer against near-term operational cash flow challenges. However, operating cash flow is negative at TWD -13,570,000, and free cash flow is also negative at TWD -19,522,000, signaling pressure on cash generation. Profitability metrics are weak, with a return on equity of -12.02% and a return on assets of -10.39%, both significantly below the industry median for Commodity Chemicals. Gross profit of TWD 2,172,000 on revenue of TWD 81,919,000 implies a gross margin of 2.65%, which is likely below the industry average for this sector. The company reported an operating loss of TWD -37,100,000 and a net loss of TWD -33,650,000, reflecting a challenging operating environment. Geographically, Mortech Corp's revenue is concentrated in Taiwan, the Americas, and Asia, with no disclosed breakdown of regional contributions. The company's international trade business and investment consulting services may provide diversification, but the primary revenue source remains its polyimide film manufacturing operations. No material segment disclosures are available to assess product or regional concentration risk. Growth trajectory is uncertain, with no forward-looking revenue guidance provided. Historical performance shows a decline in profitability, and the company's operating cash flow and free cash flow are negative, which may constrain reinvestment and expansion opportunities. The absence of positive operating cash flow and the net loss suggest the company is not currently generating value from its core operations. Risk factors include liquidity risk due to negative operating cash flow and free cash flow, though the company's high cash reserves mitigate this risk. There are no immediate filing-based liquidity or dilution flags, and the dilution potential is assessed as low. The company's capital expenditure of TWD -3,077,000 indicates some investment in operations, but the scale is small relative to total assets. Recent events include the latest financial filing, which discloses the operating and net losses, but no material events or earnings call transcripts are available to assess management's strategic direction or operational performance. The company's exposure to geopolitical drivers in the Commodity Chemicals industry is not quantified in the available data, but the sector is generally sensitive to global supply chain disruptions and raw material price volatility.

30-day price · 7419-48.50 (-28.0%)
Low$117.50High$236.00Close$124.50As of15 May, 00:00 UTC
Profile
CompanyMortech Corp
Ticker7419.TWO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Mortech Corp is a Taiwan-based manufacturer and seller of polyimide film used as heat-resistant insulating material for electronic motor applications, including soft printed circuit boards, high-temperature tapes, integrated circuits, and insulation for electrical appliances.

Classification. Mortech Corp is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with 92% confidence.

Mortech Corp's capital structure is characterized by a low debt-to-equity ratio of 0.08, indicating a conservative leverage profile, and a high current ratio of 9.59, suggesting strong short-term liquidity. The company holds significant cash and equivalents of TWD 142,675,000, which is 44.4% of total assets, providing a buffer against near-term operational cash flow challenges. However, operating cash flow is negative at TWD -13,570,000, and free cash flow is also negative at TWD -19,522,000, signaling pressure on cash generation. Profitability metrics are weak, with a return on equity of -12.02% and a return on assets of -10.39%, both significantly below the industry median for Commodity Chemicals. Gross profit of TWD 2,172,000 on revenue of TWD 81,919,000 implies a gross margin of 2.65%, which is likely below the industry average for this sector. The company reported an operating loss of TWD -37,100,000 and a net loss of TWD -33,650,000, reflecting a challenging operating environment. Geographically, Mortech Corp's revenue is concentrated in Taiwan, the Americas, and Asia, with no disclosed breakdown of regional contributions. The company's international trade business and investment consulting services may provide diversification, but the primary revenue source remains its polyimide film manufacturing operations. No material segment disclosures are available to assess product or regional concentration risk. Growth trajectory is uncertain, with no forward-looking revenue guidance provided. Historical performance shows a decline in profitability, and the company's operating cash flow and free cash flow are negative, which may constrain reinvestment and expansion opportunities. The absence of positive operating cash flow and the net loss suggest the company is not currently generating value from its core operations. Risk factors include liquidity risk due to negative operating cash flow and free cash flow, though the company's high cash reserves mitigate this risk. There are no immediate filing-based liquidity or dilution flags, and the dilution potential is assessed as low. The company's capital expenditure of TWD -3,077,000 indicates some investment in operations, but the scale is small relative to total assets. Recent events include the latest financial filing, which discloses the operating and net losses, but no material events or earnings call transcripts are available to assess management's strategic direction or operational performance. The company's exposure to geopolitical drivers in the Commodity Chemicals industry is not quantified in the available data, but the sector is generally sensitive to global supply chain disruptions and raw material price volatility.
Key takeaways
  • Mortech Corp has a strong liquidity position with a current ratio of 9.59 and significant cash reserves, but it is generating negative operating and free cash flow.
  • The company's profitability is weak, with a return on equity of -12.02% and a return on assets of -10.39%, both below industry norms.
  • Revenue is concentrated in polyimide film manufacturing, with no detailed segment or geographic breakdown provided.
  • Growth is constrained by negative cash flow and a net loss, with no clear path to improvement in the near term.
  • The company's risk profile is low in terms of dilution and liquidity, but its operational performance is a concern.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$81.9M
Gross profit$2.2M
Operating income-$37.1M
Net income-$33.6M
R&D
SG&A
D&A
SBC
Operating cash flow-$13.6M
CapEx-$3.1M
Free cash flow-$19.5M
Total assets$323.9M
Total liabilities$43.9M
Total equity$280.0M
Cash & equivalents$142.7M
Long-term debt$23.0M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$280.0M
Net cash$119.7M
Current ratio9.6
Debt/Equity0.1
ROA-10.4%
ROE-12.0%
Cash conversion40.0%
CapEx/Revenue-3.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric7419Activity
Op margin-45.3%0.4% medp25 -8.0% · p75 16.0%bottom quartile
Net margin-41.1%2.3% medp25 -11.6% · p75 11.8%bottom quartile
Gross margin2.7%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-3.8%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity8.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 18:30 UTC#0049588d
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 18:32 UTCJob: 973a5a93